The largest database of trusted experimental protocols

Valganciclovir

Manufactured by Merck Group
Sourced in United States

Valganciclovir is a pharmaceutical product manufactured by Merck Group. It is a type of antiviral medication used to treat certain viral infections. The core function of Valganciclovir is to inhibit viral replication, thereby reducing the severity and duration of viral infections.

Automatically generated - may contain errors

3 protocols using valganciclovir

1

Neuronal Progenitor Ablation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
5′‐Bromo‐deoxyuridine (BrdU, 100 mg/kg, Sigma) was delivered via intraperitoneal injection once a day for 3 consecutive days starting 72 hr after surgery to verify the efficiency in ablating dividing neuronal progenitors while feeding with valganciclovir‐containing chow. valganciclovir (Valcyte, Genetech) was mixed with regular grain‐based rodent diet to produce 900 mg/kg valganciclovir‐containing chow (Custom Animal Diets, LLC, Easton, PA) (Yu et al., 2015). valganciclovir chow was provided ad libitum for valganciclovir‐treated groups until the conclusion of the experiments (Figure 1a). Sham‐operated and injured mice were housed separately to allow approximately equal intake.
+ Open protocol
+ Expand
2

Teratoma Formation and Elimination in NOG Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
NOG (NOD/Shi‐scid IL2Rgnull) mice, aged 6–8 weeks, were maintained under specific‐pathogen‐free conditions in the Animal Center of the Central Institute for Experimental Animals in accordance with the guidelines of the facility. The recipient mice were anesthetized by inhalation of isoflurane (Dainippon Pharmaceutical Co., Ltd., Japan, Osaka). For subcutaneous transplantation, HSV‐TK knockin hiPSCs (TK#1–3, 3–5 × 105 cells) suspended in 0.1 ml of a 1:1 mixture of growth factor reduced Matrigel (BD Bioscience, San Jose, CA, USA) and Williams' Medium E (Thermo Fisher Scientific), were subcutaneously inoculated into mice. The mice were monitored daily and the teratomas were measured using calipers. Teratoma volume (TV) was calculated using the formula TV = ½ × A × B2 (A: length [mm]; B: width [mm]). The criteria for successive engraftment were as follows: progressive nodule growth at the site of injection and TV values exceeding 10 mm3. After 5 weeks, 0.2 mg/ml of valganciclovir (Sigma–Aldrich, St. Louis, MO, USA) or saline (Otsuka Pharmaceutical, Tokyo, Japan) was added to the drinking water. At 21–25 days after GCV or vehicle administration, teratomas were recovered from the sacrificed mice.
+ Open protocol
+ Expand
3

Transplantation of Human Cells in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female FNRG recipients were withdrawn from NTBC 4 to 5 d prior to surgery. Male TK-NOG mice 7 wk of age received 48 h of 0.1 mg/mL valganciclovir (Sigma Aldrich) in drinking water 14 d prior to transplantation (19 (link)). uPA+/− mice were transplanted 8 d after retrorsine injection when they were 20 to 21 d old. Human cells were transplanted as described previously (11 ). Briefly, under sterile conditions and using isoflurane anesthesia, the skin was cleaned with povidone iodine, and a 0.5- to 1-cm incision was created over the left flank, after which the peritoneum was mobilized and opened. The ventral tip of the spleen was mobilized onto the peritoneum, and human cells were injected into the spleen using a 28-gauge insulin syringe. After hemostasis was achieved by applying pressure to the injection site, the peritoneum was closed using 4.0 Vicryl suture (Ethicon) and the skin was closed using metal Mikron Autoclips (BD Biosciences). Mice received two doses of postoperative buprenorphine (Abbot Animal Health) 0.05 mg/kg for analgesia. Metal clips were removed 14 d after surgery.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!